Cerenome (CNSY) Research & Development (2011 - 2026)
Powered by 
Analysis
Cerenome (CNSY) Research & Development (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | -486.00 Mn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 651.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | 394.92 Mn |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 612.28 Mn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 413.13 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 97.90 Mn |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 210.03 Mn |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | 4.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.27 Mn |
| Mar 31, 2026 | 2.87 Mn |
| Dec 31, 2025 | 2.94 Mn |
| Sep 30, 2025 | 2.44 Mn |
| Jun 30, 2025 | 1.25 Mn |
| Mar 31, 2025 | 1.76 Mn |
| Dec 31, 2024 | 2.19 Mn |
| Sep 30, 2024 | 2.86 Mn |
| Jun 30, 2024 | 2.77 Mn |
| Mar 31, 2024 | 2.76 Mn |
| Dec 31, 2023 | 75,000.00 |
| Sep 30, 2023 | 2.49 Mn |
| Jun 30, 2023 | 1.42 Mn |
| Mar 31, 2023 | 2.98 Mn |
| Dec 31, 2022 | 2.14 Mn |
| Sep 30, 2022 | 2.95 Mn |
| Jun 30, 2022 | 2.83 Mn |
| Mar 31, 2022 | 1.79 Mn |
| Dec 31, 2021 | 1.60 Mn |
| Sep 30, 2021 | 1.49 Mn |